Hitchin, United Kingdom

Christopher R Self

This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1988-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher R Self. Retrieved from https://idiyas.com/inventor/christopher-r-self

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1988-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher R. Self: Innovator in Medicinal Chemistry

Introduction

Christopher R. Self, based in Hitchin, GB, is a prominent inventor known for his significant contributions to medicinal chemistry. With two patents to his name, he focuses on the development of pharmaceutical compounds with therapeutic applications, particularly in treating inflammatory conditions.

Latest Patents

Among his latest innovations, Self has developed substituted isoxazole derivatives that can serve as medicaments for various diseases, including rheumatoid arthritis, inflammatory respiratory diseases, and shock associated with ischemia. The compounds he has formulated demonstrate a complex arrangement of functional groups, aimed at maximizing their efficacy in medical applications. Another notable patent involves oxazole and isoxazole derivatives that possess anti-arthritic activity, showcasing his ongoing commitment to tackling serious health issues through innovative chemical solutions.

Career Highlights

Currently, Christopher R. Self is associated with Hoffmann-La Roche Inc., a global leader in pharmaceuticals known for its innovative research and development. His work in this esteemed organization underscores his commitment to advancing medical science through practical inventions that address critical health challenges.

Collaborations

Throughout his career, Self has collaborated with several notable colleagues in the field, including John M. Osbond and Peter J. Machin. These partnerships highlight the importance of teamwork in driving forward breakthroughs in medicinal research and the development of patentable inventions.

Conclusion

Christopher R. Self stands out as a dedicated inventor whose work is critical to the advancement of treatments for inflammatory diseases. With his two patents, he exemplifies the spirit of innovation and the impact of collaborative efforts in the pursuit of medical advancements. His contributions ensure a brighter future for patients requiring effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…